PA
BSX icon

Pineridge Advisors’s Boston Scientific BSX Stock Holding History

Pineridge Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33
Closed -$3.54K – 474
2025
Q2 		$3.54K Sell
33
-5
-13% -$506 ﹤0.01% 352
2025
Q1 		$3.83K Sell
38
-129
-77% -$13K ﹤0.01% 345
2024
Q4 		$14.9K Buy
167
+111
+198% +$9.77K 0.01% 252
2024
Q3 		$4.69K Hold
56
– – ﹤0.01% 354
2024
Q2 		$4.31K Hold
56
– – ﹤0.01% 384
2024
Q1 		$3.83K Sell
56
-5
-8% -$321 ﹤0.01% 394
2023
Q4 		$3.53K Buy
+61
New +$3.26K ﹤0.01% 553

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pineridge Advisors's BSX Position: Q3 2025 in Review

Pineridge Advisors sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 33 shares — an estimated $3.54K sold.

Pineridge Advisors first reported a position in BSX in Q4 2023 and held it in 7 quarters. The position peaked at $14.9K in Q4 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Pineridge Advisors reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 33 Boston Scientific shares in Q3 2025, an estimated $3.54K.
  • Pineridge Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 7 quarters.
  • Pineridge Advisors's Boston Scientific position peaked at $14.9K in Q4 2024.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.